Dr. Dima Dandachi, MD
Claim this profileGSK Investigational Site
Studies Human Immunodeficiency Virus Infection
Studies Coronavirus
4 reported clinical trials
6 drugs studied
Affiliated Hospitals
Clinical Trials Dima Dandachi, MD is currently running
Reparixin
for Acute Respiratory Distress Syndrome
Study objectives 1. To characterize the efficacy of reparixin in ameliorating lung injury and systemic inflammation and expediting clinical recovery and liberation from mechanical ventilation in adult patients with moderate to severe ARDS (PaO2/FIO2 ratio ≤ 200). 2. To evaluate the safety of reparixin vs. placebo in patients enrolled in the study.
Recruiting0 awards Phase 29 criteria
Reparixin
for COVID-19
This trial is testing a medication called reparixin, taken by mouth, to see if it can help adults hospitalized with severe lung infections like pneumonia and COVID-19. The goal is to see if reparixin can reduce inflammation and stop the disease from getting worse. Patients will receive reparixin along with their usual care. Reparixin has been tested in various critical settings and shown potential in improving survival in patients at high risk for in-hospital mortality.
Recruiting1 award Phase 34 criteria
More about Dima Dandachi, MD
Clinical Trial Related2 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Dima Dandachi, MD has experience with
- Reparixin
- Matching Placebo
- Cabotegravir OLI
- APRETUDE
- VH3810109
- Cabotegravir
Breakdown of trials Dima Dandachi, MD has run
Human Immunodeficiency Virus Infection
Coronavirus
Pneumonia
Infections
Coronavirus Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Dima Dandachi, MD specialize in?
Dima Dandachi, MD focuses on Human Immunodeficiency Virus Infection and Coronavirus. In particular, much of their work with Human Immunodeficiency Virus Infection has involved treating patients, or patients who are undergoing treatment.
Is Dima Dandachi, MD currently recruiting for clinical trials?
Yes, Dima Dandachi, MD is currently recruiting for 2 clinical trials in Columbia Missouri. If you're interested in participating, you should apply.
Are there any treatments that Dima Dandachi, MD has studied deeply?
Yes, Dima Dandachi, MD has studied treatments such as Reparixin, Matching Placebo, Cabotegravir OLI.
What is the best way to schedule an appointment with Dima Dandachi, MD?
Apply for one of the trials that Dima Dandachi, MD is conducting.
What is the office address of Dima Dandachi, MD?
The office of Dima Dandachi, MD is located at: GSK Investigational Site, Columbia, Missouri 65212 United States. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.